Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Dec 3, 2026 (in 49 days)
Similar opportunities open now
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Dec 3, 2026 (in 49 days)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2027
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2027
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses May 2027
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2027
Classification and identifiers
- Solicitation number
- PAR-24-296
- Assistance listing (CFDA)
- 93.989
Amount
Amount not listed here. Check the official program.
Who can apply
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that invo...
About this opportunity
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-.The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the ...